Abstract

13TH SAUDI SOCIETY FOR

RHEUMATOLOGY CONFERENCE

13TH SAUDI SOCIETY FOR

RHEUMATOLOGY CONFERENCE

Submission

Guidelines

For Abstract and Young Investigator

Submission Deadline: 25th of December, 2026

Outlined below are the guidelines that must be followed when submitting your work to SSRC-2027.

  • Original abstracts are strongly recommended
  • All submissions must be in English. English is the official conference language and all presentations must also be in English.
  • Submission titles must not be longer than 20 words and must clearly indicate the nature of the presentation
  • Submissions must not exceed 400 words, be clear and concise, highlight relevant aspects, findings and conclusions
  • Only standard abbreviations may be used within submissions- References are not required for submissions.
  • The abstract title, section headings and references are not included in the overall word count.
  • Abstracts should follow the following format:
    1. Background/Purpose: background or statement of purpose
    2. Methods: methods, materials and analytical procedure used
    3. Results: summary of the results in sufficient detail to support conclusion (we do not recommend including “results will be discussed”)
    4. Conclusion: conclusions reached
    5. Tables, graphs and images are permitted within submissions (maximum 2)
  • What is an encore presentation?
    • An encore presentation is one where you have already presented the submitted work before. For example if you have presented the work at another rheumatology event.
  • *SSRC accept encore presentations
    1. Encore presentations are permitted as long as work has been presented after SSRC 2027.
    2. Encore presentations are permitted as long as work has not previously been published prior to submission.
    3. Encore submissions are required to disclose the name and date of the event where it has been presented

Abstract Template

Title:

  • Author name1, Author name2, … (presenter name is bold and underlined)
  • 1Author’s affiliation and full address: 12 point type, centered, italicized
  • 2Author’s affiliation and full address: 12 point type, centered, italicized
  • Presenter’s e-mail address: 12 point type, centered, italicized


Introduction (or Purpose): This section must include a concise description of the background or rationale for the study, with the specific purposes, questions addressed, and/or hypotheses tested. Lengthy descriptions of rationale are not necessary and not desirable.

Method: The Method section must describe the study design and general procedures including characteristics and numbers of participants and data collection methods. If the study does not involve primary data collection, information should be provided on the methods used to summarize previously reported data (e.g., narrative or systematic review, meta-analysis).


Results: The Results section should summarize findings as they apply directly to the stated purposes of the article. If the project is ongoing and no results are available at the time of submission, please include projected results.


Conclusions: The Conclusions section must state specifically the extent to which the stated purposes of the article have been met or, if the study is ongoing, the potential implications (theoretical and/or clinical) of the findings.

Presentation Formats

Presentation Formats
Abstracts can be submitted for either oral or E-poster presentations.

Oral Presentations:
Authors whose abstracts are selected for oral presentation will be invited to present their work during the conference.
Each presentation will include a PowerPoint presentation followed by a question-and-answer (Q&A) session with the audience.

E-Poster Presentations:
Authors whose abstracts are selected for an E-poster presentation will be invited to showcase their research through an electronic poster displayed during the conference.

Abstract Review

Conditions of Acceptance

Terms and Conditions

KEY

DATES